These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection. Turell MJ; Parker MD Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440 [TBL] [Abstract][Full Text] [Related]
7. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611 [TBL] [Abstract][Full Text] [Related]
8. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514 [TBL] [Abstract][Full Text] [Related]
9. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162 [TBL] [Abstract][Full Text] [Related]
10. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. Rosas CT; Paessler S; Ni H; Osterrieder N Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789 [TBL] [Abstract][Full Text] [Related]
11. Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. Hart MK; Lind C; Bakken R; Robertson M; Tammariello R; Ludwig GV Vaccine; 2001 Nov; 20(3-4):616-22. PubMed ID: 11672929 [TBL] [Abstract][Full Text] [Related]
12. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698 [TBL] [Abstract][Full Text] [Related]
13. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus]. Filatenkov AG; Khaltaeva GG; Lukin EP; Gorban' SG; Khamitova MF; Shkurnikova NN Biull Eksp Biol Med; 1991 Mar; 111(3):287-90. PubMed ID: 2054507 [TBL] [Abstract][Full Text] [Related]
14. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety. Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542 [TBL] [Abstract][Full Text] [Related]
15. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates. Turell MJ; O'Guinn ML; Parker MD Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414 [TBL] [Abstract][Full Text] [Related]